| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |